Sona Nanotech has signed a binding licensing agreement with in-vitro diagnostics developer Arlington Scientific to market the former’s quick saliva Covid-19 test. According to the deal, Sona will license the intellectual property for its rapid saliva Covid-19 test to Arlington. Arlington will seek an Emergency Use Authorisation from the US Food and Drug Administration for usage at the point-of-care as well as for at-home settings. Arlington can produce and supply the test in the US on obtaining approval. In lab studies, the test demonstrated a sensitivity and specificity of 93% and 100%, respectively.
Japan has plans to offer free Covid-19 tests to people showing no symptoms of SARS-Cov-2 infection. The move is anticipated to protect the country from another potential Covid-19 wave. To date, Covid-19 tests are offered free to individuals experiencing virus-associated symptoms and those exposed to infection. Testing centres will be chosen by prefectural governments. Covid-19 has claimed over 18,000 lives in the country so far.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Several mayors from both sides of the US-Canada border have held discussions to urge the Canadian federal government to scrap the expensive Covid-19 test mandate for fully vaccinated travellers, CBC has reported. Following 19 months of closure, the US has now reopened the land border for fully inoculated tourists. Border-town mayors noted that vaccinated people who enter Canada are required to provide negative results from an expensive molecular test.
